Trials / Conditions / Stage III Osteosarcoma AJCC v7
Stage III Osteosarcoma AJCC v7
3 registered clinical trials studyying Stage III Osteosarcoma AJCC v7.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or H NCT03213678 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanc NCT03155620 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma NCT02243605 | National Cancer Institute (NCI) | Phase 2 |